Thermo Fisher [TMO] vs Danaher [DHR] Detailed Stock Comparison

Thermo Fisher Scientific Inc.

NYSE
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Thermo Fisher Scientific Inc. wins in 13 metrics, Danaher Corporation wins in 7 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Thermo Fisher Scientific Inc. Danaher Corporation Better
P/E Ratio (TTM) 25.84 34.61 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 3.31 2.40 Danaher Corporation
Debt-to-Equity Ratio 82.91 37.17 Danaher Corporation
PEG Ratio 2.29 3.84 Thermo Fisher Scientific Inc.
EV/EBITDA 19.02 17.69 Danaher Corporation
Profit Margin (TTM) 15.15% 14.89% Thermo Fisher Scientific Inc.
Operating Margin (TTM) 17.89% 22.94% Danaher Corporation
EBITDA Margin (TTM) 17.89% 22.94% Danaher Corporation
Return on Equity 13.52% 7.08% Thermo Fisher Scientific Inc.
Return on Assets (TTM) 5.00% 4.19% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $6.29B $5.26B Thermo Fisher Scientific Inc.
Dividend Yield 0.38% 0.56% Danaher Corporation
1-Year Return 16.53% -10.25% Thermo Fisher Scientific Inc.
Price-to-Sales Ratio (TTM) 3.86 5.10 Thermo Fisher Scientific Inc.
Enterprise Value $214.76B $140.38B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 4.75 5.67 Thermo Fisher Scientific Inc.
Gross Profit Margin (TTM) N/A 60.34% N/A
Revenue per Share (TTM) $120 $35 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $18.18 $5.16 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 0.97 0.99 Thermo Fisher Scientific Inc.
Short % of Float 1.22% 1.10% Danaher Corporation

Thermo Fisher Scientific Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

TMO
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: Thermo Fisher Scientific Inc. vs Danaher Corporation

MetricTMODHR
Market Information
Market Cap i$174.55B$126.39B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,356,2205,174,666
90 Day Avg. Volume i2,071,5174,357,215
Last Close$473.72$181.10
52 Week Range$385.46 - $643.99$160.93 - $242.80
% from 52W High-26.44%-25.41%
All-Time High$672.34 (Dec 27, 2021)$296.06 (Sep 06, 2021)
% from All-Time High-29.54%-38.83%
Growth Metrics
Quarterly Revenue Growth0.06%0.04%
Quarterly Earnings Growth0.10%0.08%
Financial Health
Profit Margin (TTM) i0.15%0.15%
Operating Margin (TTM) i0.18%0.23%
Return on Equity (TTM) i0.14%0.07%
Debt to Equity (MRQ) i82.9137.17
Cash & Liquidity
Book Value per Share (MRQ)$141.96$74.32
Cash per Share (MRQ)$8.75$8.06
Operating Cash Flow (TTM) i$8.29B$6.44B
Levered Free Cash Flow (TTM) i$5.51B$4.57B
Dividends
Last 12-Month Dividend Yield i0.38%0.56%
Last 12-Month Dividend i$1.76$1.28

Valuation & Enterprise Metrics Analysis: Thermo Fisher Scientific Inc. vs Danaher Corporation

MetricTMO (Apr 26, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.8434.61
Forward P/E i17.1619.64
PEG Ratio i2.293.84
Price to Sales (TTM) i3.865.10
Price to Book (MRQ) i3.312.40
Market Capitalization
Market Capitalization i$174.55B$126.39B
Enterprise Value i$214.76B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i4.755.67
Enterprise to EBITDA i19.0217.69
Risk & Other Metrics
Beta i0.970.99
Book Value per Share (MRQ) i$141.96$74.32

Financial Statements Comparison: Thermo Fisher Scientific Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTMO (2025)DHR (2025)
Revenue/Sales i44.56B24.57B
Cost of Goods Sold i26.32B10.05B
COGS % of Revenue i59.1%40.9%
Gross Profit i18.24B14.52B
Gross Margin i40.9%59.1%
Research & Development i1.40B1.60B
Operating Income (EBIT) i8.11B4.69B
Operating Margin i18.2%19.1%
EBITDA i11.86B7.17B
EBITDA Margin i26.6%29.2%
Pre-Tax Income i7.31B4.23B
Pre-Tax Income % of Revenue i16.4%17.2%
Income Tax i547.00M633.00M
Income Tax % of Revenue i1.2%2.6%
Net Income (Profit) i6.72B3.61B
Profit Margin i15.1%14.7%

Balance Sheet & Liquidity Metrics

MetricTMO (2025)DHR (2025)
Cash & Equivalents i9.85B4.62B
Total Current Assets i28.71B12.76B
Total Current Assets % of Revenue i64.4%51.9%
Total Current Liabilities i15.19B6.81B
Total Current Liabilities % of Revenue i34.1%27.7%
Long-Term Debt i35.85B19.50B
Long-Term Debt % of Revenue i80.5%79.4%
Total Shareholders Equity i53.54B52.54B
Retained Earnings i59.16B46.89B
Retained Earnings % of Revenue i132.8%190.9%
Property, Plant & Equipment i02.14B

Cash Flow Statement Comparison

MetricTMO (2025)DHR (2025)
Operating Cash Flow i7.82B5.64B
Operating Cash Flow % of Revenue i17.5%23.0%
Capital Expenditures i-1.48B-1.12B
Free Cash Flow i6.29B5.26B
FCF Margin i14.1%21.4%
Debt Repayment i-3.51B-500.00M
Common Stock Repurchase i-3.00B-3.09B

Short Interest & Institutional Ownership Analysis

MetricTMODHR
Shares Short i4.54M6.94M
Short Ratio i2.381.68
Short % of Float i1.22%1.10%
Shares Outstanding i371.62M707.70M
Float Shares i371.07M630.65M
% Held by Insiders i0.17%10.78%
% Held by Institutions i95.23%85.08%
% Held by Public i4.60%4.14%

Dividend Analysis & Yield Comparison: Thermo Fisher Scientific Inc. vs Danaher Corporation

MetricTMODHR
Last 12-Month Dividend i$1.76$1.28
Last 12-Month Dividend Yield i0.38%0.56%
3-Year Avg Annual Dividend i$1.60$10.51
3-Year Avg Dividend Yield i0.08%1.11%
3-Year Total Dividends i$4.80$31.54
Ex-Dividend DateMar 13, 2026Dec 26, 2025